{"id":680,"date":"2026-03-03T07:56:17","date_gmt":"2026-03-03T07:56:17","guid":{"rendered":"https:\/\/efanet.org\/annual-report\/?page_id=680"},"modified":"2026-03-03T08:52:58","modified_gmt":"2026-03-03T08:52:58","slug":"immuniverse-precise-diagnosis-for-atopic-eczema-imi2","status":"publish","type":"page","link":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/","title":{"rendered":"Immuniverse: precise diagnosis for atopic eczema (IMI2)"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-medium\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"210\" src=\"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-300x210.png\" alt=\"\" class=\"wp-image-777\" srcset=\"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-300x210.png 300w, https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-1024x718.png 1024w, https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-768x538.png 768w, https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png 1113w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n<\/div>\n\n\n<p>ImmUniverse is an Innovative Medicines Initiative (IMI2) funded project which gathers 26 consortium partners seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema.<\/p>\n\n\n\n<p>Within the project, EFA coordinates a Patient Input Platform (PIP) together with the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA). The PIP is composed of 15 patients with atopic eczema and ulcerative colitis from 11 European countries, including members from EFA\u2019s Atopic Eczema Working Group.<\/p>\n\n\n\n<p>In 2021, EFA contributed to the development of recruitment materials, brought the patient perspective to a project manuscript and offered recommendations for the continued development of the \u2018Patient\u2019s Voice\u2019 resource on the ImmUniverse website.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ImmUniverse is an Innovative Medicines Initiative (IMI2) funded project which gathers 26 consortium partners seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. Within the project, EFA coordinates a Patient Input Platform (PIP) together with the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA). The PIP [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":662,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_2021.php","meta":{"_acf_changed":false,"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"class_list":["post-680","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report\" \/>\n<meta property=\"og:description\" content=\"ImmUniverse is an Innovative Medicines Initiative (IMI2) funded project which gathers 26 consortium partners seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. Within the project, EFA coordinates a Patient Input Platform (PIP) together with the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA). The PIP [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/\" \/>\n<meta property=\"og:site_name\" content=\"EFA - Annual Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EFAPatients\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:52:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1113\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@EFA_Patients\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/\",\"name\":\"Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo-300x210.png\",\"datePublished\":\"2026-03-03T07:56:17+00:00\",\"dateModified\":\"2026-03-03T08:52:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo.png\",\"contentUrl\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo.png\",\"width\":1113,\"height\":780},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2021\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021-2\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Care\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2021-2\\\/care\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Immuniverse: precise diagnosis for atopic eczema (IMI2)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"name\":\"EFA - Annual Report\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\",\"name\":\"EFA\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"contentUrl\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"width\":1341,\"height\":742,\"caption\":\"EFA\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EFAPatients\",\"https:\\\/\\\/x.com\\\/EFA_Patients\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/efanet\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/","og_locale":"en_GB","og_type":"article","og_title":"Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report","og_description":"ImmUniverse is an Innovative Medicines Initiative (IMI2) funded project which gathers 26 consortium partners seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. Within the project, EFA coordinates a Patient Input Platform (PIP) together with the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA). The PIP [&hellip;]","og_url":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/","og_site_name":"EFA - Annual Report","article_publisher":"https:\/\/www.facebook.com\/EFAPatients","article_modified_time":"2026-03-03T08:52:58+00:00","og_image":[{"width":1113,"height":780,"url":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@EFA_Patients","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/","url":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/","name":"Immuniverse: precise diagnosis for atopic eczema (IMI2) - EFA - Annual Report","isPartOf":{"@id":"https:\/\/efanet.org\/annual-report\/#website"},"primaryImageOfPage":{"@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/#primaryimage"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/#primaryimage"},"thumbnailUrl":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-300x210.png","datePublished":"2026-03-03T07:56:17+00:00","dateModified":"2026-03-03T08:52:58+00:00","breadcrumb":{"@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/#primaryimage","url":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","contentUrl":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","width":1113,"height":780},{"@type":"BreadcrumbList","@id":"https:\/\/efanet.org\/annual-report\/2021\/care\/immuniverse-precise-diagnosis-for-atopic-eczema-imi2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/efanet.org\/annual-report\/"},{"@type":"ListItem","position":2,"name":"2021","item":"https:\/\/efanet.org\/annual-report\/2021-2\/"},{"@type":"ListItem","position":3,"name":"Care","item":"https:\/\/efanet.org\/annual-report\/2021-2\/care\/"},{"@type":"ListItem","position":4,"name":"Immuniverse: precise diagnosis for atopic eczema (IMI2)"}]},{"@type":"WebSite","@id":"https:\/\/efanet.org\/annual-report\/#website","url":"https:\/\/efanet.org\/annual-report\/","name":"EFA - Annual Report","description":"","publisher":{"@id":"https:\/\/efanet.org\/annual-report\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/efanet.org\/annual-report\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/efanet.org\/annual-report\/#organization","name":"EFA","url":"https:\/\/efanet.org\/annual-report\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/","url":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","contentUrl":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","width":1341,"height":742,"caption":"EFA"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EFAPatients","https:\/\/x.com\/EFA_Patients","https:\/\/www.linkedin.com\/company\/efanet\/"]}]}},"coauthors":[],"author_meta":{"author_link":"https:\/\/efanet.org\/annual-report\/author\/quentin\/","display_name":"quentin"},"relative_dates":{"created":"Posted 1 month ago","modified":"Updated 1 month ago"},"absolute_dates":{"created":"Posted on 3 March 2026","modified":"Updated on 3 March 2026"},"absolute_dates_time":{"created":"Posted on 3 March 2026 07:56","modified":"Updated on 3 March 2026 08:52"},"featured_img_caption":"","featured_img":false,"series_order":"","_links":{"self":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/comments?post=680"}],"version-history":[{"count":2,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/680\/revisions"}],"predecessor-version":[{"id":778,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/680\/revisions\/778"}],"up":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/662"}],"wp:attachment":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/media?parent=680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}